n.a. (ANAC)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)

2 Charts to Play the Biotech Countertrend

Looking at technicals going against parabolic moves.

Market News: Anacor Pharmaceuticals, Herbalife Ltd, Valeant Pharmaceuticals

Market News: Anacor Pharmaceuticals, Herbalife Ltd, Valeant Pharmaceuticals

The stock markets in the United States declined due to report that the country's overall economic data have been short of expectations by the most in six years. Sign up for our free newsletter The ...

Ackman Probe Sends Herbalife Soaring - Icahn, Soros Reap the Benefits

Ackman Probe Sends Herbalife Soaring - Icahn, Soros Reap the Benefits

Anacor Pharmaceuticals Inc. (NASDAQ:ANAC), Herbalife Ltd. (NYSE:HLF) and ChipMOS Technologies (NASDAQ:IMOS) reached midday with big gains this Friday. Sears Hometown and Outlet Stores (NASDAQ:SHOS), C...

Strong On High Volume: Anacor Pharmaceuticals (ANAC)

Strong On High Volume: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a strong on high relative volume candidate

Anacor Pharmaceuticals Announces Presentations At The American Academy Of Dermatology Annual Meeting

Anacor Pharmaceuticals Announces Presentations At The American Academy Of Dermatology Annual Meeting

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that the following abstracts have been accepted for presentation at the upcoming 73 rd Annual Meeting of the American Academy of Dermatology to be held in San...

Anacor Pharmaceuticals Reports 2014 Fourth Quarter And Year-End Financial Results

Anacor Pharmaceuticals Reports 2014 Fourth Quarter And Year-End Financial Results

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced its financial results for the fourth quarter and year ended December 31, 2014.

New Lifetime High Reached: Anacor Pharmaceuticals (ANAC)

New Lifetime High Reached: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a new lifetime high candidate

How to Tell When Pullback's Over?

Investors may breathe sigh of relief too soon.

Anacor Pharmaceuticals Announces 2014 Fourth Quarter And Year-End Financial Results Conference Call And Webcast

Anacor Pharmaceuticals Announces 2014 Fourth Quarter And Year-End Financial Results Conference Call And Webcast

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) will release its financial results for the fourth quarter and year ended December 31, 2014, on Thursday, March 12, 2015 at approximately 4:00 p.

Anacor Pharmaceuticals To Present At The 35th Annual Cowen Health Care Conference

Anacor Pharmaceuticals To Present At The 35th Annual Cowen Health Care Conference

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that Paul Berns, the company's Chairman, President and Chief Executive Officer, will provide a company overview at the 35 th Annual Cowen Health Care Conference on...

Anacor Pharmaceuticals (ANAC) Hits New Lifetime High

Anacor Pharmaceuticals (ANAC) Hits New Lifetime High

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a new lifetime high candidate

Insider Trading Alert - RPXC, ANAC And CZNC Traded By Insiders

Insider Trading Alert - RPXC, ANAC And CZNC Traded By Insiders

Stocks with insider trader activity include RPXC, ANAC and CZNC

First Week of ANAC August 21st Options Trading

First Week of ANAC August 21st Options Trading

Investors in Anacor Pharmaceuticals Inc saw new options begin trading this week, for the August 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 231 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Commit To Purchase Anacor Pharmaceuticals At $20, Earn 11.8% Annualized Using Options

Commit To Purchase Anacor Pharmaceuticals At $20, Earn 11.8% Annualized Using Options

Investors considering a purchase of Anacor Pharmaceuticals Inc stock, but tentative about paying the going market price of $31.20/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August 2015 put at the $20 strike, which has a bid at the time of this writing of $1.55.

Insider Trading Alert - BLUE, ANAC And FRME Traded By Insiders

Insider Trading Alert - BLUE, ANAC And FRME Traded By Insiders

Stocks with insider trader activity include BLUE, ANAC and FRME

Anacor Pharmaceuticals To Present At The 2014 Credit Suisse Healthcare Conference

Anacor Pharmaceuticals To Present At The 2014 Credit Suisse Healthcare Conference

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that Paul Berns, the company's President and Chief Executive Officer, will provide a company overview at the 2014 Credit Suisse Healthcare Conference on ...

Anacor Pharmaceuticals Reports Third Quarter 2014 Financial Results

Anacor Pharmaceuticals Reports Third Quarter 2014 Financial Results

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced its financial results for the quarter ended September 30, 2014.

New Lifetime High For Anacor Pharmaceuticals (ANAC)

New Lifetime High For Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a new lifetime high candidate

Anacor Pharmaceuticals Announces Third Quarter 2014 Financial Results Conference Call And Webcast

Anacor Pharmaceuticals Announces Third Quarter 2014 Financial Results Conference Call And Webcast

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) will release its financial results for the third quarter ended September 30, 2014, on Thursday, November 6, 2014 at approximately 4:00 p.

Strong On High Relative Volume: Anacor Pharmaceuticals (ANAC)

Strong On High Relative Volume: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a strong on high relative volume candidate

Anacor Pharmaceuticals (ANAC) Reaches New Lifetime High Today

Anacor Pharmaceuticals (ANAC) Reaches New Lifetime High Today

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a new lifetime high candidate

3 Stocks Spiking on Unusual Volume

3 Stocks Spiking on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Anacor Pharmaceuticals, Inc. Announces Pricing Of Offering Of $75 Million Of 2.00% Convertible Senior Notes Due 2021

Anacor Pharmaceuticals, Inc. Announces Pricing Of Offering Of $75 Million Of 2.00% Convertible Senior Notes Due 2021

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today the pricing of its offering of $75,000,000 aggregate principal amount of 2.

Anacor Pharmaceuticals, Inc. Announces Proposed Offering Of $70 Million Of Convertible Senior Notes Due 2021

Anacor Pharmaceuticals, Inc. Announces Proposed Offering Of $70 Million Of Convertible Senior Notes Due 2021

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that it intends to offer, subject to market and other considerations, $70,000,000 aggregate principal amount of Convertible Senior Notes due 2021 (the...

Insider Trading Alert - NDAQ, ANAC And RNR Traded By Insiders

Insider Trading Alert - NDAQ, ANAC And RNR Traded By Insiders

Stocks with insider trader activity include NDAQ, ANAC and RNR

First Week Of May 2015 Options Trading For Anacor Pharmaceuticals (ANAC)

First Week Of May 2015 Options Trading For Anacor Pharmaceuticals (ANAC)

Investors in Anacor Pharmaceuticals Inc saw new options begin trading this week, for the May 2015 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Anacor Pharmaceuticals Announces Commercial Launch Of KERYDIN (tavaborole) Topical Solution, 5% In The United States

Anacor Pharmaceuticals Announces Commercial Launch Of KERYDIN (tavaborole) Topical Solution, 5% In The United States

Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced the U.

Anacor Pharmaceuticals (ANAC) In A Perilous Reversal

Anacor Pharmaceuticals (ANAC) In A Perilous Reversal

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "perilous reversal" (up big yesterday but down big today) candidate

Anacor Pharmaceuticals Appoints Wendell Wierenga To Its Board Of Directors

Anacor Pharmaceuticals Appoints Wendell Wierenga To Its Board Of Directors

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that its Board of Directors has appointed Wendell Wierenga, Ph.

Anacor Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference

Anacor Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that Paul Berns, the company’s President and Chief Executive Officer, will provide a company overview at the Morgan Stanley Global Healthcare Conference on ...